Cargando…
Gpr18 agonist dampens inflammation, enhances myogenesis, and restores muscle function in models of Duchenne muscular dystrophy
Introduction: Muscle wasting in Duchenne Muscular Dystrophy is caused by myofiber fragility and poor regeneration that lead to chronic inflammation and muscle replacement by fibrofatty tissue. Our recent findings demonstrated that Resolvin-D2, a bioactive lipid derived from omega-3 fatty acids, has...
Autores principales: | Dort, Junio, Orfi, Zakaria, Fiscaletti, Melissa, Campeau, Philippe M., Dumont, Nicolas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461444/ https://www.ncbi.nlm.nih.gov/pubmed/37645248 http://dx.doi.org/10.3389/fcell.2023.1187253 |
Ejemplares similares
-
Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy
por: Dort, Junio, et al.
Publicado: (2021) -
Current Pharmacological Strategies for Duchenne Muscular Dystrophy
por: Yao, Shanshan, et al.
Publicado: (2021) -
Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
por: Ogura, Yuji, et al.
Publicado: (2014) -
Impaired muscle stem cell function and abnormal myogenesis in acquired myopathies
por: Deprez, Alyson, et al.
Publicado: (2023) -
Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression
por: Marini, Vittoria, et al.
Publicado: (2022)